ReWalk Robotics (LFWD): Kapitalisasi marang pendapatan

Simbol lan logo merek ReWalk Robotics (LFWD)

ReWalk Robotics Ltd. (LFWD) is scaling exoskeleton sales through Medicare support, focusing on organic growth within the B2B segment following a series of acquisitions. The P/S ratio reflects the market valuation relative to revenue, while 0.70 captures the current state of this parameter. The company's technologies create a unique mobility environment, restoring the ability to walk for paralyzed individuals and becoming an indispensable rehabilitation tool.

LFWD Multiplikator P/S ReWalk Robotics (21.02.2024 - 13.11.2026)

Rincian analitis perusahaan ReWalk Robotics Ltd (LFWD)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:LFWD rewalk.com
Barang utama ReWalk Robotics Ltd.

Demand for Lifeward rehabilitation exoskeletons ensures stable sales, making revenue assessment a key factor in analyzing the business value of ReWalk Robotics Ltd. (LFWD). The P/S ratio compares market capitalization to sales volume, allowing for the determination of whether the asset is overbought relative to its operating income, while the price-to-sales trend helps investors identify optimal entry points for a position.

Pesaing ReWalk Robotics Ltd.

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|vivani.com (VANI) - Rasio rega marang pendapatan|Xtant Medical - Rasio kapitalisasi pasar marang pendapatan|NMTC (NeuroOne Medical Technologies Corporation) - Multiplikator P/S|Rega marang dodolan Modular Med MODD|Kapitalisasi marang pendapatan MYO (Myomo, Inc)|Kapitalisasi marang pendapatan Envoy Medical Inc COCH|Multiplikator P/S VVOS (Vivos Therapeutics)|Multiplikator P/S envveno.com NVNO|SINT - Rasio rega marang pendapatan|TNON: Rasio rega marang pendapatan|autonomix.com (AMIX) - Rasio rega marang pendapatan|INVO Fertility Corp (IVF) - Multiplikator P/S|Kapitalisasi marang pendapatan BBLG|AXNX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan BIOLASE (BIOL)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Paragon 28 FNA|INVO Bioscience Inc. (INVO) - Rega marang dodolan